iShares Edge MSCI Europe Multifactor UCITS ETF EUR (Acc) USD is a equity ETF from iShares tracking the Edge MSCI Europe Multifactor index through physical replication. Domiciled in Ireland and launched in 2015, the fund manages about 606 M € and charges a TER of 0.25% — 25 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
iShares Edge MSCI Europe Multifactor UCITS ETF EUR (Acc) USD competes with 1 other products on the same index (Edge MSCI Europe Multifactor): it ranks 1st by fund size and 1st by ongoing cost, with a TER of 0.25% against a group median of 0.25%. It has been listed since 2015, 11 years of track record.
On a €10,000 investment the TER costs 25 € a year, and no product in the group costs less.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 27.1% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Ireland, which determines the tax treatment of income received by the fund and the supervisory authority.
| ASML Holding N.V. | 5.6% |
| Novartis AG | 4.1% |
| UniCredit S.p.A. | 3.1% |
| ABB Ltd | 2.5% |
| Banco Bilbao Vizcaya Argentaria SA | 2.1% |
| Credit Agricole SA | 2.0% |
| Deutsche Bank Aktiengesellschaft | 2.0% |
| UBS Group AG | 1.9% |
| AIB Group PLC | 1.9% |
| Coca Cola HBC AG | 1.9% |
| Borsa Italiana | IFSE | EUR |
| XETRA | IBC0 | EUR |
| Francoforte | IBC0 | EUR |
| London Stock Exchange | FSEU | GBX |
| London Stock Exchange | IEEU | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.